“Tealix up 17%. It's just had good news flow throughout June. Nothing major. They've spoken about new trial data. They've expanded manufacturing. It's just been a sort of good news story.”
No settled horizons yet — outcomes appear at 30/90/365 days.
Risk: max drawdown 1.7%
· volatility 0.0% ann.
· Sharpe-proxy 0.00